Overview
- Description
"UAB Inovatyvi Medicina (“IM” or the “Company”) is a Lithuanian MedTech company that develops a teleoperated robotic system – called Sentante - for executing endovascular procedures. The system aims to allow surgeons to execute some of the most critical endovascular interventions via a robotic system (e.g., to prevent heart attacks, strokes, peripheral artery disease and cancer) and is designed in a way to enable remote operations. Founded in 2017 by a strong and competent team consisting of an endovascular surgeon and medical engineers, IM claims to be at TRL 6 and aims for FDA/CE mark approval by the end of 2024 with commercialisation thereafter."
- Country
- Lithuania
- Theme
- Healthcare